We are live on
!
Find out more
EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
20 hedge funds and large institutions have $86.5M invested in ESSA Pharma in 2020 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
53% more capital invested
Capital invested by funds: $56.6M → $86.5M (+$29.9M)
18% more funds holding
Funds holding: 17 → 20 (+3)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
0.94% less ownership
Funds ownership: 68.44% → 67.51% (-0.94%)
Holders
20
Holders Change
+3
Holders Change %
+17.65%
% of All Funds
0.41%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
5
Increased
4
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$962K |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$830K |
| 3 |
Morgan Stanley
New York
|
+$597K |
| 4 |
Renaissance Technologies
New York
|
+$179K |
| 5 |
WC
Wexford Capital
West Palm Beach,
Florida
|
+$15.6K |
